QPTFF OTC
Quest PharmaTech Inc.
1W: +0.0%
1M: +50.0%
3M: +0.0%
YTD: +125.6%
1Y: +125.6%
3Y: -60.6%
5Y: -74.5%
$0.03
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$817K
+37.9% ▲
Net Income
-$2M
+40.3% ▲
EPS (Diluted)
$-0.01
+40.4% ▲
EBITDA
-$814K
+38.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $213K | $170K | $336K | $543K | $329K |
| SG&A Expenses | $874K | $639K | $536K | $819K | $488K |
| Operating Expenses | $1M | $809K | $834K | $1M | $817K |
| Operating Income | -$1M | -$809K | -$834K | -$1M | -$817K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $8K | $13K | $21K | $21K | $23K |
| Income Before Tax | $190M | -$85M | -$65M | -$3M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $190M | -$85M | -$65M | -$3M | -$2M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $1.11 | $-0.51 | $-0.39 | $-0.02 | $-0.01 |
| EBITDA | -$1M | -$789K | -$821K | -$1M | -$814K |
| Shares Outstanding | 171M | 168M | 168M | 169M | 169M |